We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Analytical Sciences Trade Fair Declared a Rousing Success

By LabMedica International staff writers
Posted on 13 Apr 2014
Organizers of this year's 24th "analytica" biosciences trade fair have reported significant increases in both the number of visitors and exhibitors compared to the 2012 event.

The analytica trade fair for laboratory technology, analysis, and biotechnology has been held at the Munich (Germany) Trade Fair Center every two years since 1968. More...
Its main exhibition sectors are the fields of analysis and quality control, biotechnology/life sciences/diagnostics, and laboratory technology.

Complementing the trade fair is the associated analytica Conference, which focuses on current and future industry topics. This international conference informs participants about the current state of analysis and its development prospects. Topics include basic and application-oriented research and development of analysis techniques in chemistry, diagnostics, molecular biology, and biochemistry.

Statistics from 2014's four-day analytica revealed that the event attracted more than 34,400 visitors (up 12.8%) with a record number of exhibitors (1,142 companies —about 11% more than in 2012). In addition to attendees from Germany, visitors to the fair came from all over the world with the largest number being from Austria, Switzerland, Italy, the United Kingdom, the United States, and China. Exhibitors represented companies from 40 countries including Germany, the United States, the United Kingdom, China, Switzerland, and France. The international exhibitors accounted for more than 39% of the exhibits, an increase of nearly 5% from the previous analytica. The increase was primarily the result of growth in the sectors for biotechnology and laboratory technology.

Dr. Wolfram Koch, managing director of the German Chemical Society and a member of the team that organizes the analytica Conference, said, "Right now, the analytica Conference is certainly one of the most important conferences in the context of analytical sciences—and not just in the German-speaking region, but also in Europe and increasingly at the global level. Among other things, that is noticeable by the fact that the number of participants from non-European countries continues to increase."

The next analytica will be held May 10–13, 2016.

Related Links:

analytica



Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.